Narcolepsy: vizsgálatok itt: Kanada
7 trials · From ClinicalTrials.gov, checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Where
- Markham, Toronto
- Életkor
- 18 év to 70 év
- People
- 150 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT07455383 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Where
- Markham, Toronto
- Életkor
- 18 év to 70 év
- People
- 176 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT07502443 - 3. fázisTaking peopleA Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Where
- Markham, Toronto
- Életkor
- 18 év to 70 év
- People
- 150 worldwide
- Run by
- Alkermes, Inc.
See details and how to joinNCT07540897 - 3. fázisTaking peopleA Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- Where
- Markham, Toronto
- Életkor
- 18 év and over
- People
- 258 worldwide
- Run by
- Harmony Biosciences Management, Inc.
See details and how to joinNCT07675135 · EU 2025-523821-17-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of E2086 in Adults With Narcolepsy
- Where
- Calgary, Markham, Ottawa, Toronto
- Életkor
- 18 év and over
- People
- 64 worldwide
- Run by
- Eisai Inc.
See details and how to joinNCT07493265 - 2. fázisTaking peopleA Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Where
- Toronto
- Életkor
- 18 év to 65 év
- People
- 248 worldwide
- Run by
- Centessa Pharmaceuticals (UK) Limited
See details and how to joinNCT06752668 · EU 2024-518929-15-00 - 2. fázisTaking peopleA Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Where
- Toronto
- Életkor
- 18 év to 65 év
- People
- 90 worldwide
- Run by
- Centessa Pharmaceuticals (UK) Limited
See details and how to joinNCT07096674 · EU 2025-522987-34-00